ArticleJournal of translational medicine2018

Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate.

Alison O'Mahony et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.